货号:GS40150
Cosibelimab (also known as CK-301) is an investigational, fully human monoclonal antibody developed as an immune checkpoint inhibitor for the treatment of cancer. It functions by blocking the interaction between a key immune checkpoint receptor on T cells and its ligands, thereby restoring and enhancing anti-tumor immune responses. Clinical trials are evaluating its safety and efficacy in patients with advanced solid tumors, including non-small cell lung cancer and cutaneous squamous cell carcinoma.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物